Reconstructive Transplantation: Program, Patient, Protocol, Policy, and Payer Considerations

[1]  L. Levin,et al.  Vascularized Composite Tissue Allografts (VCA): the Policy Side , 2016, Current Transplantation Reports.

[2]  L. Butterfield,et al.  Prospective Clinical Testing of Regulatory Dendritic Cells in Organ Transplantation , 2016, Front. Immunol..

[3]  L. Levin,et al.  A Methodology for Determining Standard of Care Status for a New Surgical Procedure: Hand Transplantation , 2016, Plastic and reconstructive surgery.

[4]  J. Plock,et al.  Premise and promise of mesenchymal stem cell-based therapies in clinical vascularized composite allotransplantation , 2015, Current opinion in organ transplantation.

[5]  K. Marra,et al.  Adipose- and Bone Marrow–Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation , 2015, Transplantation.

[6]  B. Pomahac,et al.  Facial restoration by transplantation: the Brigham and Women's face transplant experience. , 2015, Annals of plastic surgery.

[7]  J. Rubin,et al.  Effects of Immunosuppressive Drugs on Viability and Susceptibility of Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells , 2015, Front. Immunol..

[8]  E. Caterson,et al.  Cost Analysis of Conventional Face Reconstruction versus Face Transplantation for Large Tissue Defects , 2015, Plastic and reconstructive surgery.

[9]  B. Pomahac,et al.  Fortschritte in der Gesichtstransplantation , 2014, Handchirurgie Mikrochirurgie Plastische Chirurgie.

[10]  Amir H Dorafshar,et al.  Aesthetic and Functional Facial Transplantation: A Classification System and Treatment Algorithm , 2014, Plastic and reconstructive surgery.

[11]  A. Dorafshar,et al.  Algorithm for Total Face and Multiorgan Procurement From a Brain‐Dead Donor , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  X. Zheng,et al.  Perspectives on the Use of Mesenchymal Stem Cells in Vascularized Composite Allotransplantation , 2013, Front. Immunol..

[13]  J. Plock,et al.  Are cultured mesenchymal stromal cells an option for immunomodulation in transplantation? , 2013, Front. Immunol..

[14]  T. Starzl,et al.  Upper-Extremity Transplantation Using a Cell-Based Protocol to Minimize Immunosuppression , 2013, Annals of surgery.

[15]  S. Ildstad,et al.  The Need for Inducing Tolerance in Vascularized Composite Allotransplantation , 2012, Clinical & developmental immunology.

[16]  F. Rybicki,et al.  Craniofacial Principles in Face Transplantation , 2012, The Journal of craniofacial surgery.

[17]  A. Rahmel,et al.  Allocation of vascularized composite allografts: what is it? , 2012, Transplantation.

[18]  A. Donnenberg,et al.  Clinical implementation of a procedure to prepare bone marrow cells from cadaveric vertebral bodies. , 2011, Regenerative medicine.

[19]  V. Gorantla,et al.  Development of an upper extremity transplant program. , 2011, Hand clinics.

[20]  S. Schneeberger,et al.  Surgical and technical aspects of hand transplantation: is it just another replant? , 2011, Hand clinics.

[21]  G. Pierer,et al.  How reconstructive transplantation is different from organ transplantation--and how it is not. , 2011, Transplantation proceedings.

[22]  Xin Xiao Zheng,et al.  Favoring the risk-benefit balance for upper extremity transplantation--the Pittsburgh Protocol. , 2011, Hand clinics.

[23]  S. Schneeberger,et al.  Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: a translational trial in swine. , 2011, Transplantation proceedings.

[24]  E. Livingston.  Primum Non Nocere , 2011, Annals of Internal Medicine.

[25]  Vijay S. Gorantla,et al.  The effect of chondroitinase on nerve regeneration following composite tissue allotransplantation. , 2011, The Journal of hand surgery.

[26]  Kinam Park,et al.  Targeted drug delivery to tumors: myths, reality and possibility. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[27]  R. Calne,et al.  Some observations on prope tolerance , 2011, Current opinion in organ transplantation.

[28]  J. Gatherwright,et al.  Cost Analysis of Conventional Facial Reconstruction Procedures Followed by Face Transplantation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  M. Abecassis,et al.  Implementation of Vascularized Composite Allografts in the United States: Recommendations From the ASTS VCA Ad Hoc Committee and the Executive Committee , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[30]  X. Zheng,et al.  T regulatory cells and transplantation tolerance. , 2010, Transplantation reviews.

[31]  S. Schneeberger,et al.  Composite tissue allotransplantation: hand transplantation and beyond. , 2010, The Journal of the American Academy of Orthopaedic Surgeons.

[32]  V. Gorantla,et al.  Creating a hand transplant program. , 2007, Clinics in plastic surgery.

[33]  R. Calne.  Current status of clinical transplantation tolerance , 2006 .

[34]  A. Kirk,et al.  Composite Tissue Allotransplantation: Development of a Preclinical Model in Nonhuman Primates , 2005, Transplantation.

[35]  V. Gorantla,et al.  Chapter 42 – Hand and Composite Tissue Allotransplantation: Past, Present, and Future , 2005 .

[36]  Fadi G Lakkis.  Transplantation tolerance: a journey from ignorance to memory. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[37]  M. Sayegh,et al.  Memory T cells: a hurdle to immunologic tolerance. , 2003, Journal of the American Society of Nephrology : JASN.

[38]  V. Gorantla,et al.  Composite Tissue Allotransplantation (CTA): Current Status and Future Insights , 2001, European Journal of Trauma.

[39]  W. Müller‐ruchholtz.  Glances at the history of transplantation immunology. , 1999, Transplantation proceedings.

[40]  D. Gould,et al.  Non-adherence with medications in organ transplant patients: a literature review. , 1997, Journal of advanced nursing.

[41]  R. Calne,et al.  Prope tolerance: the future of organ transplantation--from the laboratory to the clinic. , 2004, Transplantation.

[42]  A. Donnenberg,et al.  Development and validation of a procedure to isolate viable bone marrow cells from the vertebrae of cadaveric organ donors for composite organ grafting. , 2012, Cytotherapy.

[43]  V. Gorantla,et al.  Immunosuppressive agents in transplantation: Mechanisms of action and current anti‐rejection strategies , 2000, Microsurgery.